Excess mortality of schizophrenia. A meta-analysis.

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry (2011) 5.46

Twenty-five year mortality of a community cohort with schizophrenia. Br J Psychiatry (2010) 2.72

Patients' and health professionals' views on primary care for people with serious mental illness: focus group study. BMJ (2005) 2.68

Mortality in schizophrenia: a measurable clinical endpoint. J Psychopharmacol (2010) 2.65

All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study. BMC Psychiatry (2010) 2.08

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study. Schizophr Res (2008) 1.97

Metabolic syndrome in people with schizophrenia: a review. World Psychiatry (2009) 1.96

Inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol (2010) 1.93

Time trends in schizophrenia mortality in Stockholm county, Sweden: cohort study. BMJ (2000) 1.77

Integrated primary mental health care: threat or opportunity in the new NHS? Br J Gen Pract (2004) 1.72

Is schizophrenia a syndrome of accelerated aging? Schizophr Bull (2007) 1.70

Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One (2013) 1.70

Five-year mortality in a cohort of people with schizophrenia in Ethiopia. BMC Psychiatry (2011) 1.66

Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull (2009) 1.40

Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study. Clin Pract Epidemiol Ment Health (2006) 1.33

Suicide risk in schizophrenia: learning from the past to change the future. Ann Gen Psychiatry (2007) 1.25

Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One (2011) 1.24

Testing the hypothesis of accelerated cerebral white matter aging in schizophrenia and major depression. Biol Psychiatry (2012) 1.21

Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull (2012) 1.14

Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization. BMC Health Serv Res (2009) 1.13

Association of psychiatric illness and all-cause mortality in the National Department of Veterans Affairs Health Care System. Psychosom Med (2010) 1.12

Pattern of mortality in a sample of Maryland residents with severe mental illness. Psychiatry Res (2010) 1.10

A behavioral weight-loss intervention for persons with serious mental illness in psychiatric rehabilitation centers. Int J Obes (Lond) (2010) 1.09

Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act (2011) 1.08

Packages of care for schizophrenia in low- and middle-income countries. PLoS Med (2009) 1.08

How do General Practitioners experience providing care for their psychotic patients? BMC Fam Pract (2007) 1.08

A cohort study on mental disorders, stage of cancer at diagnosis and subsequent survival. BMJ Open (2014) 1.05

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls. World Psychiatry (2013) 1.03

A prospective study of monitoring practices for metabolic disease in antipsychotic-treated community psychiatric patients. BMC Psychiatry (2007) 1.01

Schizophrenia, psychiatric genetics, and Darwinian psychiatry: an evolutionary framework. Schizophr Bull (2007) 1.01

Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study. J Clin Psychiatry (2010) 1.00

The paradox of premature mortality in schizophrenia: new research questions. J Psychopharmacol (2010) 0.98

Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms. Schizophr Res (2010) 0.98

Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry (2008) 0.97

Addressing long-term physical healthcare needs in a forensic mental health inpatient population using the UK primary care Quality and Outcomes Framework (QOF): an audit. Ment Health Fam Med (2008) 0.96

Cardiovascular disease risk factors in relation to suicide mortality in Asia: prospective cohort study of over one million Korean men and women. Eur Heart J (2011) 0.94

Multimodal white matter imaging to investigate reduced fractional anisotropy and its age-related decline in schizophrenia. Psychiatry Res (2014) 0.93

Schizophrenia in Thailand: prevalence and burden of disease. Popul Health Metr (2010) 0.93

Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness. BMC Psychiatry (2011) 0.93

Inequalities in lung cancer care of elderly patients with schizophrenia: an observational cohort study. Psychosom Med (2014) 0.92

Metabolic syndrome in schizophrenia. Indian J Psychol Med (2013) 0.92

Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions. Front Psychiatry (2014) 0.91

Mortality in schizophrenia and other psychoses: a 10-year follow-up of the ӔSOP first-episode cohort. Schizophr Bull (2014) 0.91

Heart disease, schizophrenia, and affective psychoses: epidemiology of risk in primary care. Community Ment Health J (2005) 0.90

Interventions for Weight Gain in Adults Treated With Novel Antipsychotics. Prim Care Companion J Clin Psychiatry (2000) 0.90

Quality of medical care for persons with serious mental illness: A comprehensive review. Schizophr Res (2015) 0.89

The association between antipsychotic agents and the risk of myocardial infarction: a systematic review. Br J Clin Pharmacol (2011) 0.89

Care for patients with severe mental illness: the general practitioner's role perspective. BMC Fam Pract (2009) 0.89

Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol (2012) 0.89

Accelerated white matter aging in schizophrenia: role of white matter blood perfusion. Neurobiol Aging (2014) 0.88

Care provided by general practitioners to patients with psychotic disorders: a cohort study. BMC Fam Pract (2010) 0.88

Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia. Gen Hosp Psychiatry (2012) 0.88

Detection of metabolic syndrome in schizophrenia and implications for antipsychotic therapy : is there a role for folate? Mol Diagn Ther (2013) 0.88

Active medical conditions among patients on an assertive community treatment team. Community Ment Health J (2006) 0.88

Early intervention in psychosis: keeping the body in mind. Br J Gen Pract (2009) 0.87

Persistent suicide risk in clinically improved schizophrenia patients: challenge of the suicidal dimension. Neuropsychiatr Dis Treat (2010) 0.86

Extracting antipsychotic polypharmacy data from electronic health records: developing and evaluating a novel process. BMC Psychiatry (2015) 0.86

Antecedents and patterns of suicide behavior in first-admission psychosis. Schizophr Bull (2009) 0.86

Atypical antipsychotics and metabolic syndrome in patients with schizophrenia: risk factors, monitoring, and healthcare implications. Am Health Drug Benefits (2011) 0.86

Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services. Clin Pract Epidemiol Ment Health (2008) 0.85

UK cost-consequence analysis of aripiprazole in schizophrenia: diabetes and coronary heart disease risk projections (STAR study). Eur Arch Psychiatry Clin Neurosci (2009) 0.85

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. J Res Med Sci (2015) 0.85

Markers of thrombogenesis are activated in unmedicated patients with acute psychosis: a matched case control study. BMC Psychiatry (2011) 0.85

Assessment of mortality and marital status of schizophrenic patients over a period of 13 years. Indian J Psychiatry (2006) 0.85

Clozapine impairs insulin action by up-regulating Akt phosphorylation and Ped/Pea-15 protein abundance. J Cell Physiol (2012) 0.83

Outcome from a community-based smoking cessation program for persons with serious mental illness. Community Ment Health J (2007) 0.83

Mean platelet volume and red cell distribution width levels in initial evaluation of panic disorder. Neuropsychiatr Dis Treat (2016) 0.83

Total and differential white blood cell counts, high-sensitivity C-reactive protein, and cardiovascular risk in non-affective psychoses. Brain Behav Immun (2014) 0.82

Increased risk of nursing home admission among middle aged and older adults with schizophrenia. Am J Geriatr Psychiatry (2009) 0.82

Improving blood and ECG monitoring among patients prescribed regular antipsychotic medications. Ment Health Fam Med (2013) 0.82

Suicide completion in secondary mental healthcare: a comparison study between schizophrenia spectrum disorders and all other diagnoses. BMC Psychiatry (2014) 0.81

A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia. Hum Genet (2008) 0.81

Total and differential white blood cell counts, high-sensitivity C-reactive protein, and the metabolic syndrome in non-affective psychoses. Brain Behav Immun (2012) 0.81

Metabolic adverse events in patients with mental illness treated with antipsychotics: a primary care perspective. Prim Care Companion J Clin Psychiatry (2008) 0.81

Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. BMC Psychiatry (2016) 0.81

Role of Long-Chain Omega-3 Fatty Acids in Psychiatric Practice. PharmaNutrition (2013) 0.80

Treatment of clozapine-associated weight gain: a systematic review. Eur J Clin Pharmacol (2015) 0.80

Cumulative stress pathophysiology in schizophrenia as indexed by allostatic load. Psychoneuroendocrinology (2015) 0.80

Rationale, design and baseline data for the Activating Consumers to Exercise through Peer Support (ACE trial): A randomized controlled trial to increase fitness among adults with mental illness. Ment Health Phys Act (2012) 0.79

Weight gain, schizophrenia and antipsychotics: new findings from animal model and pharmacogenomic studies. Schizophr Res Treatment (2010) 0.79

European network for promoting the physical health of residents in psychiatric and social care facilities (HELPS): background, aims and methods. BMC Public Health (2009) 0.79

Differential cardiac effects of aerobic interval training versus moderate continuous training in a patient with schizophrenia: a case report. Front Psychiatry (2014) 0.79

Dysphagia and Chronic Mental Illness: Looking Beyond Hysteria and Broadening the Psychiatric Differential Diagnosis. Prim Care Companion J Clin Psychiatry (2001) 0.78

Physical Health and Dual Diagnosis. Adv Dual Diagn (2008) 0.78

Quality of care for cardiometabolic disease: associations with mental disorder and rurality. Med Care (2010) 0.78

Screening for cardiovascular risk factors in adults with serious mental illness: a review of the evidence. BMC Psychiatry (2015) 0.78

Poor monitoring of physical health in patients referred to a mood disorders service. Ther Adv Psychopharmacol (2015) 0.77

Central- and autonomic nervous system coupling in schizophrenia. Philos Trans A Math Phys Eng Sci (2016) 0.77

Quality assessment of physical activity recommendations within clinical practice guidelines for the prevention and treatment of cardio-metabolic risk factors in people with schizophrenia. Community Ment Health J (2011) 0.77

Understanding the problems developing a healthy living programme in patients with serious mental illness: a qualitative study. BMC Psychiatry (2014) 0.77

Exceptional visuospatial imagery in schizophrenia; implications for madness and creativity. Front Hum Neurosci (2013) 0.77

Physical disease in schizophrenia: a population-based analysis in Spain. BMC Public Health (2010) 0.77

Sleep Disturbances and Suicide Risk in an 8-Year Longitudinal Study of Schizophrenia-Spectrum Disorders. Sleep (2016) 0.77

Mortality among long-stay patients with schizophrenia during the setting-up of community facilities under the Yuli model. Health Psychol Behav Med (2014) 0.76

Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia. Hum Brain Mapp (2016) 0.76

Adult medication-free schizophrenic patients exhibit long-chain omega-3 Fatty Acid deficiency: implications for cardiovascular disease risk. Cardiovasc Psychiatry Neurol (2013) 0.76

Evidence for Accelerated Decline of Functional Brain Network Efficiency in Schizophrenia. Schizophr Bull (2015) 0.76

The trend in mental health-related mortality rates in Australia 1916-2004: implications for policy. Aust New Zealand Health Policy (2010) 0.76

Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia. Neuropsychiatr Dis Treat (2013) 0.76

Relative Risk of Acute Myocardial Infarction in People with Schizophrenia and Bipolar Disorder: A Population-Based Cohort Study. PLoS One (2015) 0.75